These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 4309814)

  • 1. Protective effect of interferon and polyacrylic acid in newborn mice infected with a lethal dose of vesicular stomatitis virus.
    De Clercq E; De Somer P
    Life Sci; 1968 Sep; 7(17):925-33. PubMed ID: 4309814
    [No Abstract]   [Full Text] [Related]  

  • 2. Interferon administered orally: protection of neonatal mice from lethal virus challenge.
    Schafer TW; Lieberman M; Cohen M; Came PE
    Science; 1972 Jun; 176(4041):1326-7. PubMed ID: 4338344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of interferon, polyacrylin acid, and polymethacrylic acid on tail lesions on mice infected with vaccinia virus.
    De Clercq E; De Somer P
    Appl Microbiol; 1968 Sep; 16(9):1314-9. PubMed ID: 5676405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of ammonium 5-tungsto-2-antimoniate on encephalomyocarditis and vesicular stomatitis virus infections in mice.
    Werner GH; Jasmin C; Chermann JC
    J Gen Virol; 1976 Apr; 31(1):59-64. PubMed ID: 177729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-stimulating and in vivo antiviral effects of various synthetic anionic polymers.
    Merigan TC; Finkelstein MS
    Virology; 1968 Jul; 35(3):363-74. PubMed ID: 4298648
    [No Abstract]   [Full Text] [Related]  

  • 6. [Differences in the antiviral and antioncogenic action of interferons produced in murine peritoneal cells and in Krebs-2 ascitic carcinoma cells].
    Marchenko VI; Pokidysheva LN; Malinovskaia VV; Aliab'eva TI; Khesin IaE
    Vopr Virusol; 1977; (3):344-8. PubMed ID: 198969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A study of the antiviral and interferonogenic activity of various copolymers of vinylpyrrolidone].
    Zeĭtlenok NA; Vin'ner LM; Trukhmanova LB; Kropachev VA; Rodin IM; Markelova TA; Gol'dfarb MM
    Vopr Virusol; 1968; 13(4):401-8. PubMed ID: 4304409
    [No Abstract]   [Full Text] [Related]  

  • 8. Antiviral activity of interferon in rats and the effect of immune suppression.
    Schellekens H; Smiers-de Vreede E; de Reus A; Dijkema R
    J Gen Virol; 1984 Feb; 65 ( Pt 2)():391-6. PubMed ID: 6198453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating interferon in mice infected with the lactate dehydrogenase-elevating virus.
    Evans R; Riley V
    J Gen Virol; 1968 Dec; 3(3):449-52. PubMed ID: 4304104
    [No Abstract]   [Full Text] [Related]  

  • 10. Rat interferons. VI. Heterologous interferon in the treatment of viral infections.
    Lobodzińska M; Albin M
    Arch Immunol Ther Exp (Warsz); 1979; 27(1-2):247-52. PubMed ID: 220932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of interferon in the protective effect of a synthetic double-stranded polyribonucleotide against intranasal vesicular stomatitis virus challenge in mice.
    De Clercq E; Nuwer MR; Merigan TC
    J Clin Invest; 1970 Aug; 49(8):1565-77. PubMed ID: 4317283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of exogenous interferon treatment initiated after onset of multiplication of vesicular stomatitis virus in the brains of mice.
    Gresser I; Tovey MG; Bourali-Maury C
    J Gen Virol; 1975 Jun; 27(3):395-8. PubMed ID: 167120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of the efficacy of different forms of interferon therapy in the treatment of mice challenged intranassaly with vesicular stomatitis virus (VSV).
    De Clercq E; De Somer P
    Proc Soc Exp Biol Med; 1971 Oct; 138(1):301-7. PubMed ID: 4331092
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of interferon in murine lactic dehydrogenase virus infection, in vivo and in vitro.
    Dubuy H; Baron S; Uhlendorf C; Johnson ML
    Infect Immun; 1973 Dec; 8(6):977-84. PubMed ID: 4361729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of vesicular stomatitis virus with low infectivity by interferon-treated cells.
    Maheshwari RK; Friedman RM
    J Gen Virol; 1979 Jul; 44(1):261-4. PubMed ID: 227998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence and production of interferon in Rauscher virus infected mice.
    Vandeputte M; De Lafonteyne J; Billiau A; De Somer P
    Arch Gesamte Virusforsch; 1967; 20(2):235-45. PubMed ID: 4299728
    [No Abstract]   [Full Text] [Related]  

  • 17. [On the joint effect of interferon and histone on the cytopathic effect of vesicular stomatitis virus].
    Balandin IG; Diuĭsalieva RG; Kol'tsov VD; Lushnikov AA
    Vopr Virusol; 1968; 13(5):630. PubMed ID: 4303598
    [No Abstract]   [Full Text] [Related]  

  • 18. [More rapid method of microtitration of murine interferons by retarding the cytopathogenic effect of vesicular stomatitis virus].
    Pavlushina SV; Orlova TG
    Vopr Virusol; 1981; (2):242-3. PubMed ID: 6168118
    [No Abstract]   [Full Text] [Related]  

  • 19. Morphological and biochemical characterization of vesicular stomatitis virus with low infectivity released from interferon treated cells.
    Maheshwari RK; Friedman RM
    Uttar Pradesh State Dent J; 1980 Jul; 11(3):95-110. PubMed ID: 6159713
    [No Abstract]   [Full Text] [Related]  

  • 20. Protection of rabbits against local vaccinia virus infection by Brucella abortus and polyacrylic acid in the absence of systemic interferon production.
    De Clercq E; De Somer P
    Infect Immun; 1973 Oct; 8(4):669-73. PubMed ID: 4355140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.